Delivery Order SPE2DB22D1202-SPE2DB25FVLP4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,213.26 for Tranexamic 1,000 mg/100ml with sodium chloride 100ml on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price contract, which is not set-aside and was competitively awarded, represents a small-value transaction within AmerisourceBergen's broader federal medical supply portfolio. The product will be performed at the company's corporate office location...
- The Defense Logistics Agency awarded a $2,910.13 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tranexamic 1,000 mg/100 mL-NaCl 100 mL, a hemostatic agent commonly used in military and medical settings to reduce bleeding. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 3, 2025, for Tranexamic 1,000 mg/100ml-NaCl 100ml pharmaceutical supplies, with a ceiling value of $1,202.94 and firm fixed pricing. The delivery order is not set-aside and is scheduled for ultimate completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for a critical...
- The Defense Logistics Agency awarded a $1,273.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tranexamic Acid 1,000 mg/10 ml vials. This non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Tranexamic Acid 1,000 mg/10 mL in 10 mL vials, with a contract ceiling value of $1,801.51 and a firm fixed price structure. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and does not include a set-aside designation. This delivery order represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The order, valued at $4,603.22, is for the supply of 4,564,043,690 units of the medication Tranexamic Acid 1,000 mg/100 mL-Sodium Chloride 100 mL. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $2,951.92, is for the delivery of 30-count bottles of 650mg Tranexamic Acid tablets. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,202.94 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,154,614 units of tranexamic acid 1,000 mg/100 mL saline solution, a medication used to control bleeding. The award has a performance period through May 7, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of 4,566,583,729 units of Tranexamic 1,000 mg/100 ml Sodium Chloride 100 ml. The delivery order has a firm fixed price of $3,871.74 and an ultimate completion date of December 3, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Tranexamic 1000MG 10S pharmaceutical products. The contract carries a ceiling value of $14,896.27 under a firm fixed-price arrangement, with performance completed by August 29, 2025. This non-set-aside contract is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the vendor maintains its primary...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLP4Delivery Order
The Defense Logistics Agency awarded a $2,029.56 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tranexamic 1,000 mg/100ml with Sodium Chloride 100ml, with an ultimate completion date of September 18, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for tranexamic acid, a hemostatic agent commonly used in military and emergency medical settings, demonstrates the company's role as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and U.S. military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/17/25 |